Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Return on Capital Employed (2016 - 2020)

Historic Return on Capital Employed for Larimar Therapeutics (LRMR) over the last 7 years, with Q1 2020 value amounting to 1.21%.

  • Larimar Therapeutics' Return on Capital Employed fell 6400.0% to 1.21% in Q1 2020 from the same period last year, while for Mar 2020 it was 1.21%, marking a year-over-year decrease of 6400.0%. This contributed to the annual value of 0.79% for FY2019, which is 1800.0% down from last year.
  • As of Q1 2020, Larimar Therapeutics' Return on Capital Employed stood at 1.21%, which was down 6400.0% from 1.06% recorded in Q4 2019.
  • Larimar Therapeutics' Return on Capital Employed's 5-year high stood at 0.46% during Q4 2016, with a 5-year trough of 1.21% in Q1 2020.
  • Over the past 5 years, Larimar Therapeutics' median Return on Capital Employed value was 0.57% (recorded in 2017), while the average stood at 0.62%.
  • Its Return on Capital Employed has fluctuated over the past 5 years, first skyrocketed by 1600bps in 2019, then tumbled by -6400bps in 2020.
  • Larimar Therapeutics' Return on Capital Employed (Quarter) stood at 0.46% in 2016, then fell by -24bps to 0.57% in 2017, then grew by 5bps to 0.54% in 2018, then tumbled by -97bps to 1.06% in 2019, then decreased by -15bps to 1.21% in 2020.
  • Its Return on Capital Employed stands at 1.21% for Q1 2020, versus 1.06% for Q4 2019 and 0.65% for Q3 2019.